Related Experiment Videos
Mitral valve replacement six years after cardiac transplantation
J G Copeland1, L J Rosado, G Sethi
1Section of Cardiovascular and Thoracic Surgery, University of Arizona Health Sciences Center, Tucson.
The Annals of Thoracic Surgery
|June 1, 1991
Summary
A cardiac transplant recipient with worsening mitral regurgitation and reduced exercise capacity underwent successful mitral bioprosthesis implantation. Eight months post-surgery, the patient shows significant clinical and hemodynamic improvement without complications.
Area of Science:
- Cardiology
- Cardiac Surgery
- Transplantation Medicine
Background:
- Cardiac transplantation is a life-saving procedure for end-stage heart failure.
- Mitral regurgitation can develop or progress years after cardiac transplantation.
- Reduced exercise tolerance is a common symptom of significant mitral regurgitation.
Observation:
- A 33-year-old male recipient of cardiac transplantation presented with progressive mitral regurgitation.
- The patient experienced a decline in exercise capacity 6 years post-transplant.
- A mitral bioprosthesis was surgically implanted to address the valvular dysfunction.
Findings:
- The mitral bioprosthesis implantation was performed without immediate complications.
- Post-operative follow-up at 8 months revealed no adverse events related to the valve replacement.
- The patient demonstrated substantial clinical improvement and enhanced hemodynamic function.
Implications:
- Mitral bioprosthesis implantation is a viable and effective treatment for mitral regurgitation in cardiac transplant recipients.
- Successful valve replacement can significantly improve the quality of life and functional capacity in this patient population.
- This case highlights the importance of vigilant monitoring for valvular complications after cardiac transplantation.